Aigen Investment Management’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-23,719
Closed -$257K 956
2023
Q1
$257K Buy
+23,719
New +$257K 0.04% 465
2020
Q4
Sell
-4,663
Closed -$69K 1039
2020
Q3
$69K Sell
4,663
-8,766
-65% -$130K 0.01% 754
2020
Q2
$282K Buy
13,429
+3,477
+35% +$73K 0.04% 630
2020
Q1
$230K Buy
9,952
+9,933
+52,279% +$230K 0.03% 664
2019
Q4
$0 Buy
+19
New ﹤0.01% 1147